{"id":"NCT00840086","sponsor":"Novo Nordisk A/S","briefTitle":"Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects","officialTitle":"A Multi-centre, Open-label, Non-controlled Trial on Safety and Efficacy of N8 in Prevention and Treatment of Bleeds in Previously Treated Subjects With Haemophilia A. Sub-trial: Safety and Efficacy of N8 in Prevention and Treatment of Bleeding During Surgical Procedures in Subjects With Haemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2011-09","completion":"2011-09","firstPosted":"2009-02-10","resultsPosted":"2014-09-04","lastUpdate":"2017-03-17"},"enrollment":150,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Congenital Bleeding Disorder","Haemophilia A"],"interventions":[{"type":"DRUG","name":"turoctocog alfa","otherNames":[]}],"arms":[{"label":"rFVIII","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Asia, Europe, and North and South America. The trial consists of a main trial and a sub-trial. The main trial investigates safety and efficacy of turoctocog alfa (recombinant factor VIII, rFVIII (N8)) in haemophilia A subjects, while the sub-trial investigates safety and efficacy of turoctocog alfa in prevention and treatment of bleeding episodes during surgical procedures.","primaryOutcome":{"measure":"The Incidence Rate of FVIII Inhibitors (Greater Than or Equal to 0.6 Bethesda Units (BU))","timeFrame":"The adverse events were collected throughout the trial, corresponding to an average of 188 days per subject.","effectByArm":[{"arm":"All Subjects Treated With Turoctocog Alfa","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":63,"countries":["United States","Brazil","Croatia","Denmark","Germany","Hungary","Israel","Italy","Japan","Malaysia","Russia","Serbia and Montenegro","Serbia","Spain","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["23647704","25273984","25677761","26679394"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":150},"commonTop":["Incorrect dose administered","Headache","Nasopharyngitis"]}}